NEW YORK (GenomeWeb News) - Multispan and Promega said yesterday that they will co-develop assay tools for G-protein coupled receptor screening using Multispan’s GPCR cell lines and Promega’s bioluminescent technology.
 
The companies said that the initial tools to be developed under the agreement will use Promega’s cAMP-Glo Assay technology for signal quantification. The partners said they will develop additional tools for “cell-based assay detection,” but did not provide further details.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.